WA
GILD icon

Wealth Alliance’s Gilead Sciences GILD Stock Holding History

Wealth Alliance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Sell
2,059
-590
-22% -$77.7K 0.02% 490
2026
Q1 		$369K Sell
2,649
-4,400
-62% -$616K 0.04% 372
2025
Q4 		$865K Sell
7,049
-1,268
-15% -$154K 0.08% 206
2025
Q3 		$923K Sell
8,317
-2,131
-20% -$242K 0.1% 190
2025
Q2 		$1.16M Sell
10,448
-4,587
-31% -$488K 0.13% 150
2025
Q1 		$1.68M Sell
15,035
-4,232
-22% -$437K 0.2% 98
2024
Q4 		$1.78M Sell
19,267
-1,525
-7% -$137K 0.21% 93
2024
Q3 		$1.74M Buy
20,792
+887
+4% +$67.7K 0.21% 100
2024
Q2 		$1.37M Buy
19,905
+5,716
+40% +$381K 0.18% 114
2024
Q1 		$1.04M Buy
14,189
+2,502
+21% +$192K 0.14% 154
2023
Q4 		$947K Buy
11,687
+396
+4% +$30.8K 0.13% 154
2023
Q3 		$846K Buy
11,291
+1,038
+10% +$79.8K 0.13% 160
2023
Q2 		$790K Sell
10,253
-2,818
-22% -$225K 0.12% 177
2023
Q1 		$1.08M Sell
13,071
-7,481
-36% -$620K 0.18% 126
2022
Q4 		$1.76M Sell
20,552
-3,244
-14% -$257K 0.31% 65
2022
Q3 		$1.47M Buy
23,796
+359
+2% +$22.6K 0.29% 69
2022
Q2 		$1.45M Buy
23,437
+5,639
+32% +$349K 0.28% 79
2022
Q1 		$1.06M Buy
17,798
+1,967
+12% +$126K 0.22% 105
2021
Q4 		$1.15M Sell
15,831
-38
-0.2% -$2.62K 0.23% 100
2021
Q3 		$1.11M Buy
15,869
+427
+3% +$30K 0.25% 92
2021
Q2 		$1.06M Buy
15,442
+1,452
+10% +$97K 0.25% 94
2021
Q1 		$904K Buy
13,990
+707
+5% +$45.6K 0.25% 91
2020
Q4 		$774K Buy
13,283
+2,548
+24% +$154K 0.23% 114
2020
Q3 		$678K Buy
10,735
+6,050
+129% +$420K 0.24% 106
2020
Q2 		$360K Sell
4,685
-6,805
-59% -$522K 0.14% 186
2020
Q1 		$859K Buy
11,490
+238
+2% +$16.4K 0.46% 58
2019
Q4 		$731K Buy
+11,252
New +$733K 0.52% 51

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wealth Alliance's GILD Position: Q2 2026 in Review

Wealth Alliance reduced its Gilead Sciences (GILD) stake by 22% in Q2 2026, selling an estimated $77.7K and leaving 2,059 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #490.

Wealth Alliance first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.78M in Q4 2024. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wealth Alliance held 2,059 shares of Gilead Sciences worth $260K as of Q2 2026.
  • Wealth Alliance sold 590 Gilead Sciences shares in Q2 2026, an estimated $77.7K.
  • Gilead Sciences made up 0.02% of Wealth Alliance's portfolio in Q2 2026, its #490 holding.
  • Wealth Alliance first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Wealth Alliance's Gilead Sciences position peaked at $1.78M in Q4 2024.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealth Alliance's 13F filing for Q2 2026, filed 11 Aug 2026.